VBL prices second IPO attempt

VBL Therapeutics Ltd. (NASDAQ:VBLT) raised $40 million through the sale of 6.7 million shares at $6 in an IPO underwritten by Deutsche Bank, JMP and Oppenheimer. This is the company's second attempt at an IPO. Its August IPO was terminated by the underwriters when an investor did not make payments for shares it had agreed to purchase. At that time, the company was offering 5.4 million shares at $12 (see BioCentury Extra, August 8). ...